Shesh Rai

29PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 01, 2026
Factors Associated With Optimal Patient-Clinician Communication Among Cancer Survivors.

|Jun 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.

|Jun 23, 2026
Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity.

|Aug 06, 2025
Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancer.

Ameet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman

|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Olga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz

|Sep 27, 2024
Disparities in Clinical Trial Participation: A Cross-Sectional Survey of Cancer Patients at a Midwest Academic Medical Center.

Katie Moreland, Melinda Butsch Kovacic, Shesh Rai

Pageof 5

Frequent Collaborators

4 joint publications

Samarendra Das

3 joint publications

Trisha Wise-Draper

3 joint publications

Jianmin Pan

2 joint publications

Audrey Romano